multiple myeloma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

multiple myeloma
Jan 25, 2025, 14:04 | Science
Myeloma Paper of the Day, January 25th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 25, 2025, 12:41 | Science
Erman Akkus: Review on familial multiple myeloma
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a recent article by him and…
Jan 24, 2025, 13:24 | Insight
Myeloma Paper of the Day, January 24th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 22, 2025, 13:23 | Insight
Myeloma Paper of the Day, January 22nd, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 21, 2025, 14:12 | Insight
Myeloma Paper of the Day, January 21st, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 20, 2025, 13:23 | Blog
Al-Ola A Abdallah: Comparing Idecabtagene Vicleucel and Ciltacabtagene Autoleucel for RRMM
Al-Ola A Abdallah, Associate Professor, Plasma Cell Disorder Program Director, Division of HMCT/University of Kansas…
Jan 20, 2025, 12:28 | Insight
Myeloma Paper of the Day, January 20th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 19, 2025, 22:11 | Insight
Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared…
Jan 19, 2025, 21:04 | Insight
Al-Ola Abdallah discusses the AURIGA Study on multiple myeloma
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT…
Jan 19, 2025, 14:08 | Science
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared an article by Tingting Yue…
Jan 15, 2025, 08:14 | Blog
Chokri Ben Lamine: Immune Targets in Hematologic Malignancies
Chokri Ben Lamine, Adult Hematology and stem cell transplantation Assistant Consultant at Oncology Center of…
Jan 13, 2025, 17:37 | Blog
The top breakthroughs in multiple myeloma research unveiled at ASH24 - International Myeloma Foundation
International Myeloma Foundation shared a post on X: "The top breakthroughs in multiple myeloma research…
Jan 7, 2025, 12:06 | Science
Rahul Banerjee: Joseph Mikhael's commentary about our SWOG dexamethasone analysis
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Jan 6, 2025, 11:03 | Science
Myeloma Paper of the Day, January 6th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of trends in…
Jan 4, 2025, 13:31 | Insight
Samer Al Hadidi: The longest follow up of any myeloma phase III clinical trial
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X: “We…
Jan 3, 2025, 21:19 | Science
Outcome of Patients With CNS Multiple Myeloma Treated With CNS-Directed XRT by Gohar Manzar et al.
A recent paper by Gohar Manzar, Resident Physician at MD Anderson Cancer Center, published in Clinical…
Jan 2, 2025, 16:09 | Blog
Save the date for the IACH's Post ASH24 Webinar
IACH shared a post on X: “Save the date for The IACH's Post ASH24 Webinar:…
Jan 2, 2025, 15:48 | Blog
Why many myeloma doctors have been limiting use of dexamethasone in treatment - International Myeloma Foundation
International Myeloma Foundation shared a post on X: "Dr. Joseph Mikhael, Chief Medical Officer of…
Dec 31, 2024, 10:13 | Insight
Mahmoud Gaballa: Re outcomes of BCMA CART in CNS Multiple Myeloma
Mahmoud Gaballa, Assistant Professor in the department of Lymphoma and Myeloma at MD Anderson Cancer…
Dec 29, 2024, 12:28 | Science
Supriya Peshin: Novel Approaches in Cellular Therapy for Multiple Myeloma
Supriya Peshin, Internal Medicine Resident at Ballad Health, posted on X about recent paper by…
Dec 28, 2024, 17:33 | Science
Saurabh Zanwar: Is risk-adapted therapy ready for prime time in Multiple Myeloma?
Saurabh Zanwar, Assistant Professor at Mayo Clinic, shared on X about recent paper by him…
Dec 26, 2024, 14:23 | Insight
Study exploring the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma
Haematologica shared a post on X: “Long non-coding RNA (lncRNA) have emerged as key players…
Dec 24, 2024, 11:33 | Blog
Muhammad Umair Mushtaq: Utilizing CAR-T therapy in relapsed/refractory multiple myeloma
Muhammad Umair Mushtaq, Associate Professor of Medicine at University of Kansas Medical Center, shared a…
Dec 22, 2024, 13:29 | Science
Outpatient teclistamab step-up dosing in Multiple Myeloma
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a recent article by Tyler…
Dec 22, 2024, 10:00 | Science
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Francesco Maura, Assistant Professor of Sylvester Comprehensive Cancer Center, posted on X about recent paper…
Dec 21, 2024, 22:26 | Blog
Anas Younes: Transforming outcomes for people living with Blood Cancer
Anas Younes, Senior VP, Global Head of Hematology (Early and Late Stage), Oncology R&D at…
Dec 16, 2024, 17:18 | Blog
Rahul Banerjee: Antibody targets in smoldering multiple myeloma analyzed
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X: “Fascinating…
Dec 16, 2024, 08:42 | Blog
PETHEMA-GEM experience highlights cytogenetic abnormalities in multiple myeloma
Muzaffar Qazilbash, Stem Cell Transplant Physician and Clinical Researcher at MD Anderson Cancer Center, shared…
Dec 14, 2024, 15:32 | Insight
Myeloma Paper of the Day, December 14th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Analysis of smoldering…
Dec 13, 2024, 17:37 | Blog
Moffitt Cancer Center - Potential avenues for toxicity prevention and therapeutic optimization in high-risk patients
Moffitt Cancer Center shared on LinkedIn: "In a packed ASH24 session, Doris Hansen, presented a comprehensive…
Dec 12, 2024, 20:10 | Blog
Urvi Shah was awarded the ASH's David M. Goldenberg Clinical Research Training Institute Award
Memorial Sloan Kettering Cancer Center shared on LinkedIn "Congratulations to Dr. Urvi Shah, a myeloma…
Dec 11, 2024, 14:33 | Blog
Sabrina Hanna: Visiting Kite Pharma's CAR T-Cell Manufacturing Facility
Sabrina Hanna, Chief change officer at The Cancer Collaborative and Executive Director of Save Your…
Dec 11, 2024, 13:21 | Insight
Myeloma Paper of the Day, December 11th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: AQUILA study shows patients…
Dec 11, 2024, 12:41 | Blog
Robert Orlowski on patients with newly diagnosed multiple myeloma to benefit from Isa-VRd as initiation therapy
MD Anderson Cancer Center shared on X: "Patients with newly diagnosed multiple myeloma may benefit from…
Dec 10, 2024, 13:33 | Blog
Rahul Banerjee: Robert Z. Orlowski presented updated IMROZ MRD Multiple Myeloma data
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted on X: "ASH24 well, this…
Dec 10, 2024, 12:41 | Blog
Nikhil Vojjala: Racial representation among studies for MM NCCN guidelines
Nikhil Vojjala, MD in Internal Medicine at Trinity Health MI, shared a post on X:…
Dec 10, 2024, 07:06 | Blog
Samer Al Hadidi: Discontinuation of Lenalidomide Maintenance after ASCT in MM
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X: “Oral…
Dec 9, 2024, 17:55 | Blog
Shahrin Ahmed: The treatment of multiple myeloma is being improved
Shahrin Ahmed, Medical Specialist oncology at Canadian Cancer Society and Associate Professor at Staffordshire University,…
Dec 9, 2024, 14:30 | Insight
Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory Multiple Myeloma
Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a article by…
Dec 8, 2024, 06:51 | Insight
Nico Gagelmann: Suggesting Bispecific Antibodies as Standard of Care for Relapse After CAR-T in Multiple Myeloma
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a recent article on X: "Finally out…
Dec 4, 2024, 21:31 | Blog
Join us in supporting cancer researchers this Giving Tuesday - ASCO
ASCO - American Society of Clinical Oncology reposted a post by Conquer Cancer, the ASCO…
Dec 4, 2024, 14:15 | Insight
Myeloma Paper of the Day, December 4th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: A systematic review and meta-analysis…
Nov 30, 2024, 15:51 | Insight
Myeloma Paper of the Day, November 30th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: High level of circulating cell-free…
Nov 21, 2024, 16:11 | Blog
Mike Thompson: Myeloma/Plasma Cell Dyscrasia - Top Abstract Highlights from ASH24
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:…
Nov 21, 2024, 14:56 | Insight
Samer Al Hadidi: Immune microenvironment alterations in Multiple Myeloma
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X: “Check…
Nov 18, 2024, 17:13 | Blog
Vincent Rajkumar: Working on refining response criteria in myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on…
Nov 17, 2024, 12:23 | Insight
Samer Al Hadidi: Quadruplets as Top Option in Transplant-Ineligible Multiple Myeloma
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on LinkedIn: "Quadruplets…
Nov 13, 2024, 10:52 | Blog
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO/DARZALEX…
Nov 12, 2024, 17:56 | Insight
Daratumumab+ Lenalidomide vs Lenalidomide for Post-Transplant Maintenance in Multiple Myeloma
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a recent article by…
Nov 12, 2024, 15:53 | Insight
Myeloma Paper of the Day, November 12th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of predictors of local…
Nov 8, 2024, 13:40 | Insight
Myeloma Paper of the Day, November 8th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Results of a Phase 1b…
Nov 1, 2024, 15:23 | Insight
Myeloma Paper of the Day, November 1st, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Integrated functional genomic analysis of…
Oct 31, 2024, 15:16 | Insight
Myeloma Paper of the Day, October 31st, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Forimtamig, a novel…
Oct 31, 2024, 06:01 | Insight
Nico Gagelmann: Bs Abs as bridging to BCMA CAR-T cell therapy for R/R multiple myeloma
Nico Gagelmann, Co- Chair of the The EBMT Trainee Committee, shared on X: “Finally out!…
Oct 30, 2024, 15:18 | Insight
Myeloma Paper of the Day, October 30th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Retrospective evaluation of…
Oct 27, 2024, 11:46 | Blog
Vincent Rajkumar: Key recommendations for CART and bispecifics for relapsed myeloma
Vincent Rajkumar posted on X: "Key recommendations for CART and bispecifics for relapsed myeloma presented…
Oct 22, 2024, 23:30 | Blog
Murali Janakiram: Common questions about Bispecifics and CART in Multiple Myeloma
Murali Janakiram, Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City…
Oct 19, 2024, 13:59 | Insight
Myeloma Paper of the Day, October 19th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Case series of patients…
Oct 18, 2024, 12:58 | Blog
Rahul Banerjee: Multicenter description of immune effector cell-associated enterocolitis as a novel toxicity of CAR T-cell therapy in multiple myeloma
Rahul Banerjee shared a post on X, about recent paper published in Blood Cancer Journal:…
Oct 16, 2024, 14:56 | Blog
5th How to Diagnose and Treat: Multiple Myeloma
5th How to Diagnose and Treat: Multiple Myeloma will be held at Vienna Austria from…
Oct 16, 2024, 14:26 | Blog
Rahul Banerjee: An area where we need more research!
Rahul Banerjee shared a post by Nature Medicine on X, adding the following: “Relevant to…
Oct 14, 2024, 11:47 | Blog
Honoring John Gallin, the 10th and longest-serving director of the NIH Clinical Center
John I. Gallin, M.D., the 10th director of the National Institutes of Health (NIH) Clinical…
Oct 12, 2024, 16:23 | Insight
Myeloma Paper of the Day, October 12th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Pharmacovigilance study of…
Oct 11, 2024, 16:19 | Insight
Myeloma Paper of the Day, October 11th, suggested by Robert Orlowski
Robert Orlowski shared about the Myeloma Paper of the Day. Read about the article on…
Oct 9, 2024, 12:36 | Insight
Myeloma Paper of the Day, October 9th, suggested by Robert Orlowski
Robert Orlowski shared about the Myeloma Paper of the Day. Read about the article on…
Oct 4, 2024, 17:11 | Blog
Registration opens for the 7th Translational Research Conference on Multiple Myeloma - ESH
ESH (European School of Haematology) shared a post on X: ''Our Team is ready to…
Oct 4, 2024, 15:20 | Insight
Rahul Banerjee: Dexamethasone 40mg weekly in Multiple Myeloma induction
Rahul Banerjee shared his recent article on X: "Grateful to Blood Journal, co-authors, and SWOG…
Sep 30, 2024, 18:22 | Blog
Rahul Banerjee: Don’t say “atypical abnormal” unless it is
Rahul Banerjee shared a post on X: "IMS24 see the future of FISH reporting in Multiple…
Sep 24, 2024, 11:34 | Blog
Rahul Banerjee: A picture worth a thousand words
Rahul Banerjee shared a post on X, about recent paper published in The Lancet Haematology:…
Sep 23, 2024, 16:26 | Blog
Tom Snow: The FDA approved our combination therapy for adults with newly diagnosed Multiple Myeloma
Olivier Nataf, Global Head of Oncology at Sanofi, shared a post by Tom Snow on…
Sep 20, 2024, 14:26 | Blog
Malin Hultcrantz: Colesevelam for treatment of lenalidomide associated diarrhea
Elias K. Mai, Board Certified Specialist in Internal Medicine, Hematology and Oncology at University Hospital…
Sep 20, 2024, 08:50 | Insight
Santiago Thibaud: Multiple Myeloma Risk and Outcomes Associated with PGVs in DNA Repair Genes
Santiago Thibaud shared on X: "New paper in Blood Cancer Discovery! Thrilled to announce our…
Sep 18, 2024, 14:06 | Blog
Maximilian Merz: A comeback of checkpoint inhibition in Multiple Myeloma
Maximilian Merz, Head of Early Clinical Trials Unit Leipzig (ECTUL) at Leipzig University, shared a…
Sep 17, 2024, 14:23 | Insight
Myeloma Paper of the Day, September 17th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: A phase I study of MAGE-A1-targeted…
Sep 10, 2024, 10:28 | Blog
Matthew Herper: Facing cancer is hard -- even if you're someone who would change the way we treat cancer
Matthew Herper, Senior Writer, Medicine, and Editorial Director, Events at STAT, made the following post…
Sep 9, 2024, 09:26 | Blog
Rahul Banerjee: AURIGA results in IMS 2024 app
Rahul Banerjee shared a post on X: ''AURIGA results in the International Myeloma Society (IMS)…
Sep 8, 2024, 10:38 | Insight
Myeloma Paper of the Day, September 8th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Retrospective case-control study with Korea National Health…
Sep 7, 2024, 14:48 | Insight
MD Anderson Research Highlights
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Sep 5, 2024, 15:19 | Insight
Myeloma Paper of the Day, September 5th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Metformin augments GPRC5D expression in…
Sep 5, 2024, 00:05 | Blog
The International Myeloma Foundation has helped bring over 17 treatments for multiple myeloma to market
International Myeloma Foundation shared a post on X: “The International Myeloma Foundation has helped bring…
Sep 1, 2024, 15:09 | Blog
Joselle Cook: Raising awareness for multiple myeloma at the annual Minneapolis MMRF WALK
Joselle Cook, Assistant Professor of Medicine at Mayo Clinic, shared a post on X: ''We’re…
Sep 1, 2024, 08:24 | Insight
Rahul Banerjee: Chronicle disparities in Relapsed or Refractory myeloma and why they matter
Rahul Banerjee shared on X: "Now in Blood Cancer Journal - our work to chronicle…
Aug 29, 2024, 11:32 | Blog
The upcoming IACH event for Patients in French
IACH (International Academy for Clinical Hematology) shared a post on X: ''Join us for the…
Aug 27, 2024, 09:40 | Insight
Myeloma Paper of the Day, August 27th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Study using cryo-EM to elucidate…
Aug 25, 2024, 20:14 | Blog
CPOEM Foundation's first support group webinar for patients with multiple myeloma
CPOEM Foundation posted on LinkedIn: "We kicked off our first support group webinar on August…
Aug 24, 2024, 07:20 | Blog
Saad Usmani joins the ICE expedition to raise money for MM research - IMF
International Myeloma Foundation (IMF) shared a post on X: "Dr. Saad Usmani joins the ICE (Iceland…
Aug 23, 2024, 13:45 | Insight
Myeloma Paper of the Day, August 23rd, suggested by Robert Orlowski
Robert Z. Orlowski shared a post on X: "Myeloma Paper of the Day: Study of teclistamab…
Aug 23, 2024, 12:25 | Insight
Jonathan Keats: 12 Days of CoMMpass – Day 4
Jonathan Keats shared on X: “12 Days of CoMMpass – Day 4: Today we will…
Aug 22, 2024, 16:01 | Blog
Annual Updates in the Management of Multiple Myeloma - UNC Lineberger Cancer Network
UNC Lineberger Cancer Network posted on X: "Samuel M. Rubinstein, MD, MSCI, presents on Annual…
Aug 22, 2024, 04:05 | Insight
Jonathan Keats: 12 Days of CoMMpass - Day 2
Jonathan Keats shared on X: “12 Days of CoMMpass – Day 2: The intention of…
Aug 21, 2024, 13:44 | Insight
MMRF Fast Facts in Myeloma Series
Multiple Myeloma Research Foundation shared on X: “Our MMRF Fast Facts in Myeloma series is…
Aug 20, 2024, 14:29 | Blog
Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?
Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…
Aug 15, 2024, 04:56 | Blog
Hung Trinh: A novel CAR-Enhancer to prevent relapse after CAR-T Therapy by Dana-Farber Cancer Institute
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Aug 14, 2024, 10:29 | Insight
Rahul Banerjee: They say not all MRD negativity in myeloma is created equal
Rahul Banerjee shared on X: "They say not all MRD negativity in myeloma is created…
Aug 14, 2024, 07:24 | Career
Christine Ryland as Director of Thought Leader Liaison for the multiple myeloma team at Kite Pharma
Christine Ryland shared on LinkedIn: "I’m happy to share that I have started a new position…
Aug 13, 2024, 12:34 | Insight
Myeloma Paper of the Day, August 13th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Nationwide registry study of patients…
Aug 12, 2024, 22:03 | Blog
Rahul Banerjee: Timothy Schmid about whole-body MRI imaging in multiple myeloma at DAVA Heme
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "DAVA Heme and now Timothy…
Aug 12, 2024, 12:52 | Blog
Erik Ellefsen: Got to share a bit of my myeloma story at OCS and met another myeloma warrior
Erik Ellefsen, Cancer Survivor and Patient Advocate, shared on X: "Got to share a bit…
Aug 12, 2024, 12:46 | Blog
Rahul Banerjee: Sanam Loghavi is the best pathologist in the world
Sanam Loghavi shared a post by Rahul Banerjee, Assistant Professor at UW Medicine, on X: "Have…
Aug 12, 2024, 03:20 | Blog
Using lymphocyte count to predict CAR-T cell therapy efficacy in relapsed multiple myeloma
WCM Myeloma Center posted on X: "New research led by Drs. Mateo Mejia, Ruben Niesvizky…
All: 269 Posts: 1 - 100
Special Coverage